Universal Health Services, Inc. company logo

# 1st Gen Model Universal Health Services, Inc. General medical & surgical hospitals

66.67% successful of 81 deals
$113.44 Last close price
at 15-dec-2017


Model's trade recommendations 1.46% Return for period

2.15% Annual return

$10.81B Market Cap

β 0.97  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 1.46%
52wk return -9.81%
52wk Range
Sortino ratio 0.26
Sharpe ratio 0.20
Norm. RMSE 0.78%
Downside risk 10.52%
Volatility 13.23%
  • 0.40 (0.35%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Universal Hospital Services, Inc. is a leading, nationwide provider of health care technology management and service solutions. UHS owns or manages more than 700,000 units of medical equipment for more than 7,000 national, regional and local acute care hospitals and alternate site providers across the U.S. For more than 75 years, UHS has delivered medical equipment management and service solutions that help clients reduce costs, increase operating efficiencies, improve caregiver satisfaction and support optimal patient outcomes. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Industry sector: Medical

Sector classification: General medical & surgical hospitals

Deep Learning based analysis and prediction model for Universal Health Services, Inc. (UHS) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for UHS model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 82M
P/E 15.23
Shares Outstanding 95M
% Held by Insiders 13.20%
% Held by Institutions 86.13%
EPS (last reported FY) $7.32
EPS (last reported Q) $1.64
EPS, estimated (last reported Q) $1.70
Total revenues $10 B
Net income $1 B